Thursday, November 14, 2019
Search

Johnson - search results

If you're not happy with the results, please do another search

Scientists Discover the Possible Cause of Talc-Related Ovarian Cancer

A study recently published in the journal Reproductive Sciences has found the possible mechanism by which talc exposure causes ovarian cancer. A great deal...

Surgical Mesh: A Brief (and Checkered) History

Surgical mesh consists of a loosely woven sheet, made from both biological and artificial materials that have been used in a variety of corrective...

Uloric Risks and Alternatives

Since the FDA added a boxed warning to Uloric for elevated risk of fatal cardiovascular events in February 2019, physicians and patients who take...

J&J’s Baby Powder Ads Targeted Minority and Overweight Women

According to internal company documents, Johnson & Johnson marketing campaigns for Baby Powder and Shower to Shower were focused primarily on women who were...

Drug Companies Lobbying To Raise Drug Prices For Senior Citizens

Major pharmaceutical companies just can’t seem to get enough cash, and they are now lobbying the federal government to get Medicare drug discounts for...

FDA Approves New Indication for Xarelto

New Jersey-based drugmaker Johnson & Johnson (JNJ) and its partner, Bayer AG, received approval for a new indication for the controversial anti-coagulant medication Xarelto...

Xarelto Fails to Prevent Clotting in Recent Trial

Johnson & Johnson’s and Bayer's recent attempt to expand the market for its controversial anticoagulant, Xarelto, encountered a setback when the medication failed to...

Jury Awards $4.6 Billion in Talcum Powder Cancer Case

Johnson & Johnson recently got hit with nearly five billion dollars by a jury for covering up the dangers of their talcum powder products....

The First Glyphosate Cancer Lawsuit Trial Begins This Week

46-year-old DeWayne Johnson of Bernicia, California is a husband and father of three children. He worked for the local school district as a groundskeeper...

Why Has Pfizer Discontinued Research on Neurodegenerative Diseases?

In January, pharmaceutical giant Pfizer announced that it would stop all funding for research into neurodegenerative diseases, specifically Parkinson's and Alzheimer's. In a media...